Advertisement
*
Reproduction permitted for personal use only. For reprints and reprint permission, contact reprints@wistechnology.com.

Third Wave announces two senior management appointments

Madison, Wis.Third Wave Technologies, Inc. has added two executives to its senior management team, including an attorney that helped litigate Third Wave's successful patent infringement suit against Stratagene Corp.

The company also announced that it would host a conference call on Tuesday, April 25, during which it will report its first quarter earnings.

Third Wave, which develops and markets molecular diagnostic reagents, said Tuesday that Cindy S. Ahn has been appointed vice president and general counsel. She previously worked for the Kirkland & Ellis law firm, where she was a partner and key member of the team that successfully litigated Third Wave's patent infringement suit against Stratagene Corp. The suit resulted in a $20.1 million award to Third Wave.

Prior to entering law school, Ahn served as a technician at Abbott Laboratories. She earned a bachelor of science degree in biology at the University of Illinois and a law degree from American University's Washington College of Law.

Meanwhile, Jorge A. Garces, Ph.D., has been appointed vice president of product and platform development. Garces joined Third Wave in October 2005 as executive director of clinical development. Prior to joining Third Wave, he served as director of molecular research and development at Genzyme Genetics.
Advertisement
Garces earned his bachelor's degree in biology from Brooklyn College and his doctorate in cell and molecular biology from the City University of New York. He completed his post-doctoral training at the University of Massachusetts Medical School.

The April 25 conference call will be held at 9 a.m. Central Standard Time, and will include a live Webcast that can be accessed at http://www.twt.com. Domestic callers may dial (800) 599-9795, and international callers should dial (617) 786-2905. The access code for both domestic and international callers is 35772390.

To accelerate the development of Third Wave's personalized genetic tests for diseases such as hepatitis, and to advance market penetration into Asian markets, the company recently announced a new partnership with Mitsubishi Corp. in which Mitsubishi and another firm will invest $5 million in Third Wave Japan, a unit of Third Wave Technologies. With this infusion of capital, Mitsubishi will gain a 14 percent ownership of Third Wave Japan, and CSK Holdings Corp. will gain about 3 percent ownership.

-Add Your Comment

Name:
E-mail:

Comment Policy: WTN News accepts comments that are on-topic and do not contain advertisements, profanity or personal attacks. Comments represent the views of the individuals who post them and do not necessarily represent the views of WTN Media or our partners, advertisers, or sources. Comments are moderated and not immediately posted. Your email address will not be posted.

WTN Media cannot accept liability for the content of comments posted here or verify their accuracy. If you believe this comment section is being abused, contact edit@wistechnology.com.

Advertisement
Advertisement
WTN Media Presents